Cerebras IPO Filing Signals Structural Shift in AI Compute Economics
Cerebras files for a $22B-$25B IPO, anchored by $24.6B in future revenue commitments and a massive strategic pivot toward OpenAI…
Curated insights, deep dives, and the radar on what's next in tech.
Cerebras files for a $22B-$25B IPO, anchored by $24.6B in future revenue commitments and a massive strategic pivot toward OpenAI…
Ron Conway begins a year-long treatment for a rare cancer, formalizing a leadership transition to his sons at SV Angel;…
Tesla's deployment in Dallas and Houston intensifies the battle for autonomous market share, placing the company in direct competition with…
A 24% jump in App Store submissions indicates that AI-driven development is ending an eight-year drought in mobile app launches,…
New-age tech stocks in India outperformed as market sentiment improves, with Yatra leading gains and Lenskart, Ather, and Groww hitting…
Airwallex is weaponizing its cross-border infrastructure to challenge Stripe's domestic dominance, marking the end of a long-standing period of geographic…
Google blocked 8.3 billion ads in 2025, shifting its enforcement focus from mass account suspensions to granular, AI-powered asset-level blocking.
AI-referred traffic to U.S. retailers surged 393% in Q1 2026, marking a fundamental shift in high-intent customer discovery and conversion.
How a 17-year-old student used computer vision and aggressive viral marketing to build a $10M+ ARR nutrition app in between classes.
Arushi Jain built EMORI to disrupt the legacy diamond industry by merging lab-grown technology with modern fashion-tech retail.
High-reasoning AI with native code execution and autonomous agent capabilities.
Automated System 2 reasoning for complex strategy & code.
Orchestrate complex AI agents and business workflows with the choice of cloud or self-hosting.
Build autonomous AI agents that work across your entire tech stack using natural language.
A shift toward "Wet Lab + Dry Lab" integration. Pure AI models are hitting data limits; investors are rotating back to platforms that generate novel biological data.
The "No-Code" dream is finally working via "AI-Code." Also, SoftBank is back in town.
The flight to quality. Investors are consolidating around "frontier" winners with proven revenue-per-token efficiency over pure user growth.
VCs are shifting from "pure-play" AI apps to "AI-enabled roll-ups" where existing revenue and data are bought rather than built.
Q1 2026 fundraising kick-off and global multi-city scheduling (Jan 27 in SF, NYC, LA)
This recurring global mixer series has become a staple for the "build-in-public" crowd, specifically designed to strip away the overhead of traditional conferences. The formatβfocused on 1-minute rapid-fire pitchesβforces founders to refine their value proposition to its most essential form. In a market where DeepTech is shifting from general LLM wrappers to specialized hardware and […]
This recurring global mixer series has become a staple for the “build-in-public” crowd, specifically designed to strip away the overhead of traditional conferences. The formatβfocused on 1-minute rapid-fire pitchesβforces founders to refine their value proposition to its most essential form. In a market where DeepTech is shifting from general LLM wrappers to specialized hardware and […]
Occurring just as Q1 health tech investment cycles ramp up, providing a critical window for founder-investor networking.